| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,998,200 | 3,745,000 | 3,502,800 | 3,664,100 | | Cost of Revenue | 1,630,800 | 1,543,800 | 1,490,400 | 1,613,500 | | | Gross Profit | 2,367,400 | 2,201,200 | 2,012,400 | 2,050,600 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,441,900 | 1,314,100 | 1,201,000 | 1,258,300 | | Non Recurring |
-
|
-
|
-
| 24,000 | | Others |
-
|
-
|
-
| 18,800 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 925,500 | 887,100 | 811,400 | 749,500 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 98,600 | | Earnings Before Interest And Taxes | 925,500 | 887,100 | 811,400 | 771,600 | | Interest Expense | 16,300 | 21,500 | 21,200 | 23,600 | | Income Before Tax | 909,200 | 865,600 | 790,200 | 748,000 | | Income Tax Expense | 292,500 | 277,800 | 253,700 | 251,000 | | Minority Interest | (26,200) | (26,200) | (28,600) | (80,300) | | | | Net Income From Continuing Ops | 590,500 | 561,600 | 507,900 | 497,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 590,500 | 561,600 | 507,900 | 497,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $590,500 | $561,600 | $507,900 | $497,000 |
|
0.31% Nasdaq 0.00%
Income Statement
